Results 181 to 190 of about 86,023 (206)

Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancer. [PDF]

open access: yesJ Immunother Cancer
Porter R   +20 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

An update on the immune landscape in lung and head and neck cancers

Ca-A Cancer Journal for Clinicians, 2020
Jennifer W Carlisle   +2 more
exaly  

Emerging connectivity of programmed cell death pathways and its physiological implications

Nature Reviews Molecular Cell Biology, 2020
Sammy Bedoui   +2 more
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

HPV Communication: Review of Existing Research and Recommendations for Patient Education

Ca-A Cancer Journal for Clinicians, 2004
Annekathryn Goodman
exaly  

Home - About - Disclaimer - Privacy